MedPage Today May 24, 2024
Charles Bankhead

— Large cohort study provides some of the first evidence of cancer reduction after vaccination

CHICAGO — Vaccination against human papillomavirus (HPV) reduced the risk of multiple types of cancer in both men and women, a large retrospective cohort study showed.

The risk of head and neck cancer and all HPV-associated cancers in men decreased by more than 50%. Consistent with previous reports, vaccination reduced the risk of cervical cancer by 29%, cervical cancer precursor lesions by 50-60%, and all HPV-related cancers in women by 27%. The risk of head and neck cancer in women decreased by 33%, but the difference compared with unvaccinated women did not reach statistical significance.

The data are among the first to show an association...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Patient / Consumer, Provider, Trends
Baptist Health breaks ground on medical office building, ASC
Improving the patient experience can pay dividends you may not expect
Ohio hospital files for bankruptcy
Martha's Vineyard physician practice faces closure
The massive opportunity in women's longevity

Share This Article